In appreciation of the gifts of knowledge and training, the George W. McLean estate has funded an endowment to support endocrinology research.

More children die from pneumonia than AIDS, malaria and measles combined. A DGHI researcher hopes to harness a naturally occurring bacterium to help kids fight back.

A less extensive surgical option is proving to be an effective method for treating early non-small-cell lung cancer, the most common type of lung cancer, according to a long-term, randomized trial.

Graduate students at Duke University who are laying the groundwork for new health care innovations were honored March 1 at the Chancellor’s Award for Research Excellence (CARE) ceremony.

Gift by Marion Stein, MD, to support research and faculty at the Duke Human Vaccine Institute.

Duke University School of Medicine's Dean's Distinguished Research Series kicked off on February 23 with the Robert J. Lefkowitz, MD, Distinguished Lecture by cell biologist Titia de Lange, PhD, of Rockefeller University and faculty lectures from two Duke researchers who study the genes that make us uniquely human.

When Anthony Fuller MD, MScGH, came to Duke as a medical student nine years ago, he hit the ground running. He co-founded the first division dedicated to improving global care for neurology and neurosurgery in the United States.

A groundbreaking advancement in the treatment of geographic atrophy (GA), an advanced form of dry macular degeneration happened with the approval of pegcetacoplan, the first ever FDA-approved treatment for GA.

Georgeanna J. Klingensmith's generous bequest funds a professorship in pediatrics at Duke University School of Medicine.

Dean Mary Klotman talks to Donald McDonnell, PhD, the Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology about the FDA-approved breakthrough drug for breast cancer developed in his Duke lab.